Literature DB >> 33185578

Impact of lockdown for COVID-19 pandemic in Indian children and youth with type 1 diabetes from different socio-economic classes.

Nikhil Shah1, Madhura Karguppikar1, Shital Bhor1, Dipali Ladkat1, Vaman Khadilkar1,2, Anuradha Khadilkar1,2.   

Abstract

Objectives In March 2020, lockdown was imposed in India to combat spread of Coronavirus, which was extended till 31st May. Implementation of lockdown and limited outdoor activities resulted in changes in routines of children with diabetes. The aim of this study was to assess the impact of lockdown on glycemic control, weight and body mass index (BMI) patterns of children with type 1 diabetes (T1DM) from different socio-economic (SE) classes. Methods This observational study included 77 children and youth (5-20 years) with T1DM having disease duration of ≥6 months. Demographic data and investigations were recorded at two time points (post lockdown when the children came for follow up, pre lockdown data from medical records). Results Glycemic control improved (pre lockdown HbA1C 79.4±19.2 vs. post lockdown Hba1C 74.5±16.9 mmol/mol, p<0.05) and there was weight gain post lockdown (pre lockdown weight z-score -0.4±0.8 vs. post lockdown weight z-score -0.2±0.8, p<0.05) without any significant change in BMI and insulin requirements. Improved glycemic was seen in the lower SE group control post lockdown (p<0.05), whereas in higher SE group, it remained unchanged. Children whose parents were at home during lockdown showed an improved glycemic control (p<0.05) as compared to children whose parents continued to work during lockdown (p>0.01) Conclusions During coronavirus lockdown, glycemic control was adequately maintained in children with T1DM, highlighting importance of stronger family support system leading to more steady daily routine.

Entities:  

Keywords:  COVID-19; India; children; coronavirus; glycemic control; lockdown; type 1 diabetes; weight gain

Year:  2020        PMID: 33185578     DOI: 10.1515/jpem-2020-0460

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  6 in total

1.  COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020.

Authors:  Benjamin Udoka Nwosu; Layana Al-Halbouni; Sadichchha Parajuli; Gabrielle Jasmin; Emily Zitek-Morrison; Bruce A Barton
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-10       Impact factor: 6.055

2.  Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.

Authors:  Emilia Biamonte; Francesco Pegoraro; Flaminia Carrone; Isabella Facchi; Giuseppe Favacchio; Andrea Gerardo Lania; Gherardo Mazziotti; Marco Mirani
Journal:  Endocrine       Date:  2021-05-05       Impact factor: 3.633

3.  Improvement in glycaemic control in paediatric and young adult type 1 diabetes patients during COVID-19 pandemic: role of telemedicine and lifestyle changes.

Authors:  Pietro Lazzeroni; Matteo Motta; Sara Monaco; Serena Rosa Laudisio; Daria Furoncoli; Valentina Maffini; Monica Rubini; Bertrand Tchana; Claudio Ruberto; Icilio Dodi; Brunella Iovane
Journal:  Acta Biomed       Date:  2021-11-03

4.  The Effect of Lockdown and Physical Activity on Glycemic Control in Italian Children and Young Patients With Type 1 Diabetes.

Authors:  Nicola Minuto; Marta Bassi; Carolina Montobbio; Francesco Vinci; Claudia Mercuri; Francesca Nastasia Perri; Mara Cabri; Maria Grazia Calevo; Giuseppe d'Annunzio; Mohamad Maghnie
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-13       Impact factor: 5.555

5.  Glycemic control among children and adolescents with type 1 diabetes during COVID-19 pandemic in Egypt: a pilot study.

Authors:  Yasmine Ibrahim Elhenawy; Khadiga Yehia Eltonbary
Journal:  Int J Diabetes Dev Ctries       Date:  2021-07-09

6.  Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies.

Authors:  Giovanni Antonio Silverii; Chiara Delli Poggi; Ilaria Dicembrini; Matteo Monami; Edoardo Mannucci
Journal:  Acta Diabetol       Date:  2021-06-22       Impact factor: 4.280

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.